arXiv subjects

Ruihan Luo

Publications and source records attributed to Ruihan Luo.

3 recordsLinked to original sources

arXiv2026

Flash-Radiomics: A Scalable Hybrid CPU-CUDA Engine for Standardized Scalar Radiomics and Accelerated Spatial Mapping

Background and Objectives: Spatial mapping retains the spatial distribution of radiomic features, but computational cost and fragmented software limit its use. We developed Flash-Radiomics with scalar extraction and spatial mapping, a central processing unit (CPU) backend, a hybrid Compute Unified Device Architecture (CUDA) backend, consistent feature names, and Hierarchical Data Format version 5 (HDF5) storage. Methods: We evaluated Image Biomarker Standardisation Initiative (IBSI) compliance, CPU-CUDA concordance, and end-to-end processing time. Compliance testing included 825 chapter 1 (IBSI-1) tests covering 165 high-consensus features and 323 chapter 2 (IBSI-2) tests with numerical references. Concordance testing included 1,148 scalar pairs and 93 spatial-map pairs. End-to-end processing time was measured five times per input volume of interest (VOI) size. Comparisons included the Medical Image Radiomics Processor (MIRP) and PyRadiomics for 102 shared scalar features and PyRadiomics for 93 shared spatial maps. Results: Both backends passed all 1,148 IBSI tests, and all paired results were concordant. At the largest scalar input, CPU required 76.343 s and hybrid CUDA 81.915 s; CPU was 4.7 times faster than MIRP and 190.7 times faster than PyRadiomics. At the largest spatial input completed by both backends, hybrid CUDA reduced processing time by 68.6% relative to CPU (79.280 versus 252.791 s). At PyRadiomics' largest completed spatial input, hybrid CUDA was 84.9 times faster. Conclusions: Flash-Radiomics unified standardized scalar extraction, spatial mapping, concordant CPU-CUDA results, and HDF5 storage. CPU processing time was similar or shorter for scalar extraction, whereas hybrid CUDA was faster for spatial mapping under the tested conditions.

q-bio.OT↗

arXiv2025

SeqUDA-Rec: Sequential User Behavior Enhanced Recommendation via Global Unsupervised Data Augmentation for Personalized Content Marketing

Personalized content marketing has become a crucial strategy for digital platforms, aiming to deliver tailored advertisements and recommendations that match user preferences. Traditional recommendation systems often suffer from two limitations: (1) reliance on limited supervised signals derived from explicit user feedback, and (2) vulnerability to noisy or unintentional interactions. To address these challenges, we propose SeqUDA-Rec, a novel deep learning framework that integrates user behavior sequences with global unsupervised data augmentation to enhance recommendation accuracy and robustness. Our approach first constructs a Global User-Item Interaction Graph (GUIG) from all user behavior sequences, capturing both local and global item associations. Then, a graph contrastive learning module is applied to generate robust embeddings, while a sequential Transformer-based encoder models users' evolving preferences. To further enhance diversity and counteract sparse supervised labels, we employ a GAN-based augmentation strategy, generating plausible interaction patterns and supplementing training data. Extensive experiments on two real-world marketing datasets (Amazon Ads and TikTok Ad Clicks) demonstrate that SeqUDA-Rec significantly outperforms state-of-the-art baselines such as SASRec, BERT4Rec, and GCL4SR. Our model achieves a 6.7% improvement in NDCG@10 and 11.3% improvement in HR@10, proving its effectiveness in personalized advertising and intelligent content recommendation.

cs.IR↗

arXiv2025

A Multi-Layered Framework for Modeling Human Biology: From Basic AI Agents to a Full-Body AI Agent

We envision the Full-Body AI Agent as a comprehensive AI system designed to simulate, analyze, and optimize the dynamic processes of the human body across multiple biological levels. By integrating computational models, machine learning tools, and experimental platforms, this system aims to replicate and predict both physiological and pathological processes, ranging from molecules and cells to tissues, organs, and entire body systems. Central to the Full-Body AI Agent is its emphasis on integration and coordination across these biological levels, enabling analysis of how molecular changes influence cellular behaviors, tissue responses, organ function, and systemic outcomes. With a focus on biological functionality, the system is designed to advance the understanding of disease mechanisms, support the development of therapeutic interventions, and enhance personalized medicine. We propose two specialized implementations to demonstrate the utility of this framework: (1) the metastasis AI Agent, a multi-scale metastasis scoring system that characterizes tumor progression across the initiation, dissemination, and colonization phases by integrating molecular, cellular, and systemic signals; and (2) the drug AI Agent, a system-level drug development paradigm in which a drug AI-Agent dynamically guides preclinical evaluations, including organoids and chip-based models, by providing full-body physiological constraints. This approach enables the predictive modeling of long-term efficacy and toxicity beyond what localized models alone can achieve. These two agents illustrate the potential of Full-Body AI Agent to address complex biomedical challenges through multi-level integration and cross-scale reasoning.

q-bio.TO↗